A
Avalyn Pharma
1 follower
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases.
Org chart
Lyn Baranowski
Collapse
Mark Surber
Founder & Chief Scientific Officer
Howard M. Lazarus
Chief Medical Officer
Michelle Patterson
SVP, Program Management
Stephen Pham
VP, Product Development
Alyssa Black
Associate Director Human Resources
Board & advisors
Niall O’Donnell
Chairman
Jonathan Leff
Director
Ketan Patel
Director
Sofia Ioannidou
Director
Tiba Aynechi
Director
Peter Moldt
Director